Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 354.26M P/E - EPS this Y 11.10% Ern Qtrly Grth -
Income -64.4M Forward P/E -9.21 EPS next Y 50.00% 50D Avg Chg -3.00%
Sales 171.36M PEG - EPS past 5Y - 200D Avg Chg 41.00%
Dividend N/A Price/Book 11.78 EPS next 5Y - 52W High Chg -16.00%
Recommedations 1.50 Quick Ratio 1.71 Shares Outstanding 148.26M 52W Low Chg 166.00%
Insider Own 2.69% ROA -8.55% Shares Float 143.83M Beta 1.29
Inst Own 41.94% ROE -617.16% Shares Shorted/Prior 11.41M/11.09M Price 2.58
Gross Margin 82.90% Profit Margin -37.58% Avg. Volume 1,188,125 Target Price 4.58
Oper. Margin -35.05% Earnings Date Aug 8 Volume 669,522 Change -4.09%
About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Xeris Biopharma Holdings, Inc. News
07/25/24 Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
07/24/24 Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?
07/08/24 Xeris Biopharma Announces CEO Succession Plan
07/03/24 Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/06/24 Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit
06/03/24 Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
05/30/24 Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
05/30/24 Xeris to Participate in the Jefferies Global Healthcare Conference
05/10/24 Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges
05/10/24 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
05/10/24 Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations
05/09/24 Q1 2024 Xeris Biopharma Holdings Inc Earnings Call
05/09/24 Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
05/09/24 Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
05/06/24 Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
05/02/24 Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock
05/02/24 Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
04/17/24 Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
04/05/24 Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
04/03/24 Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS Chatroom

User Image Bearly_Bullish_Trader Posted - 7 hours ago

$xers @Postnl @Mannix1961 you two still alive??

User Image Bearly_Bullish_Trader Posted - 10 hours ago

$XERS @acinvestor13 Hope you opened a new short today.

User Image SparkyReturns Posted - 10 hours ago

$XERS https://www.zacks.com/stock/news/2307853/xeris-biopharma-xers-now-trades-above-golden-cross-time-to-buy?cid=CS-MKTWTCH-HL-tale_of_the_tape|golden_crossover-2307853&mod=mw_quote_news

User Image c_sonnier Posted - 10 hours ago

$XERS Does anyone have the Gvoke numbers from last Friday?

User Image Green_Johnnie Posted - 10 hours ago

$XERS I am wrong two times in a row. Have a nice weekend.

User Image DarkOrb Posted - 11 hours ago

$XERS Highest daily and weekly close since Paul crashed the stock in early March. Uptrend continues.

User Image HorizonBull Posted - 11 hours ago

$XERS nice close

User Image Ithaca2018 Posted - 11 hours ago

$XERS Have a nice weekend!

User Image Bearly_Bullish_Trader Posted - 11 hours ago

$XERS

User Image dave2ta Posted - 11 hours ago

$XERS OK, It's Friday so It's also Song Day... This one is sad to me because I Wrote & Recorded it in November of 2022 and it's still relevent today! I was hoping it would be one of those songs you listen to and say, yeh, but that was yesterday, the world is much better today... I'm not sure we can truthfully say that right now... There is always Tomorrow so Hope is never lost. The song itself is not too bad, so please listen, think, and enjoy. https://daveevanssolo.bandcamp.com/track/world-is-all-ablaze

User Image JAAAAAY123 Posted - 12 hours ago

$XERS from @biotech

User Image ronday19200 Posted - 13 hours ago

$XERS

User Image SparkyReturns Posted - 13 hours ago

$XERS After today, only 8 more trading days til ER on August 8.

User Image Snufkin Posted - 13 hours ago

$XERS yawn...

User Image PJACOB01 Posted - 13 hours ago

$XERS Come on guys, Ithaca needs her squeeze!

User Image Universaal Posted - 13 hours ago

$XERS longs deserve min $11 as it hit back in 2022

User Image Green_Johnnie Posted - 13 hours ago

$XERS wtf. its friday. come on!

User Image simonig1 Posted - 14 hours ago

$XERS Here is a 5-day 15-minute chart showing that XERS is beating up against the Fib. Resistance 1 (FR1) which it will overcome very soon. This is normal behavior for a stock which comes up to resistance levels. FR2 will be next up.

User Image SparkyReturns Posted - 14 hours ago

$XERS We are like .40 PAST where it crossed the major moving averages.... When we get good news at ER on August 8, watch out. Cheers!

User Image SparkyReturns Posted - 15 hours ago

$XERS Not only will this stay above 2.50, this will be above 3.50 before you know it. If we get a dip near 2.50 I'm buying more.

User Image simonig1 Posted - 15 hours ago

$XERS Prepare to be Amazed! ;-)

User Image Green_Johnnie Posted - 15 hours ago

$XERS will be amazed if this stays above 2.50.

User Image Cream1987 Posted - 16 hours ago

$XERS 2.5 new add zone I think.

User Image Ithaca2018 Posted - 16 hours ago

$XERS She's coming back for more;-)

User Image HorizonBull Posted - 17 hours ago

$XERS i like that gap to be filled . very close

User Image SparkyReturns Posted - 17 hours ago

$XERS I wonder if anyone has access to Bloomberg Terminal, I think they have script data. Maybe when I have time I'll try to figure out the cost. I know through IQvia I priced data access and it was crazy expensive.

User Image BeeeeDooooh Posted - 17 hours ago

$XERS show me $2.68

User Image StarF Posted - 17 hours ago

$XERS did we ever get last week scribs?

User Image Bearly_Bullish_Trader Posted - 17 hours ago

$XERS So long as the close remains above $2.44 we're still in the game for breaking $2.61, but I dislike how this turned into an ascending triangle on the daily. It was better as an upward channel. Time for an extra big dose of hopium. #inhalesdeep

User Image Northwoodspeculator Posted - 18 hours ago

$XERS

Analyst Ratings
HC Wainwright & Co. Buy May 31, 24
Piper Sandler Overweight May 10, 24
Oppenheimer Outperform Mar 28, 24
HC Wainwright & Co. Buy Mar 7, 24
HC Wainwright & Co. Buy Nov 13, 23
Piper Sandler Overweight Nov 10, 23
Craig-Hallum Buy Aug 28, 23
HC Wainwright & Co. Buy Aug 9, 23
HC Wainwright & Co. Buy May 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schmid John P. Director Director Nov 16 Buy 1.51 6,500 9,815 6,500 11/17/23
Shannon John Patrick Jr See Remarks See Remarks Nov 17 Buy 1.638 30,769 50,400 1,408,575 11/17/23
Edick Paul R See Remarks See Remarks Aug 09 Buy 2.3794 10,000 23,794 2,288,064 08/09/23